Your gateway to Deep Piction updatesYour gateway to Deep Piction

There's something unsettling, yet mesmerizing, about a transparent mouse. Munich-based Deep Piction has built a business around making them—rendering entire rodents see-through to track how experimental drugs move through living tissue at the resolution of individual cells. The biotech startup recently closed a seed round, according to its hiring page, though it's keeping the details close: no amount disclosed, no investor names, no announcement date.

‍

There's something unsettling, yet mesmerizing, about a transparent mouse. Munich-based Deep Piction has built a business around making them—rendering entire rodents see-through to track how experimental drugs move through living tissue at the resolution of individual cells. The biotech startup recently closed a seed round, according to its hiring page, though it's keeping the details close: no amount disclosed, no investor names, no announcement date.

‍

What the company is willing to share is its ambition. Deep Piction wants to fundamentally change how pharmaceutical companies test drug delivery, and maybe—just maybe—reduce the number of animals sacrificed in the process:

‍

• There's regulatory tailwind here, at least in theory.
• The FDA Modernization Act 2.0, signed in December 2022, explicitly permits nonclinical alternatives like in vitro and in silico models where scientifically justified. Animal studies remain the gold standard, yes, but validated alternatives now have statutory legitimacy they once lacked.

‍

‍

When Lab Science Meets Commercial Reality

‍

‍

There's something unsettling, yet mesmerizing, about a transparent mouse. Munich-based Deep Piction has built a business around making them—rendering entire rodents see-through to track how experimental drugs move through living tissue at the resolution of individual cells. The biotech startup recently closed a seed round, according to its hiring page, though it's keeping the details close: no amount disclosed, no investor names, no announcement date.

What the company is willing to share is its ambition. Deep Piction wants to fundamentally change how pharmaceutical companies test drug delivery, and maybe—just maybe—reduce the number of animals sacrificed in the process.